Mequinol/tretinoin

Drug Profile

Mequinol/tretinoin

Alternative Names: 4-HA/tretinoin; 4-hydroxyanisole; 4-hydroxyanisole/tretinoin; BMS 181158; BMS 181158/BMS 181159; BMS 181159; Solage®; Solagé; Solagé Topical Solution; Tretinoin/mequinol

Latest Information Update: 09 Jan 2018

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Bristol-Myers Squibb
  • Class Anisoles; Keratolytics; Retinoids
  • Mechanism of Action Retinoic acid receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Marketed Hyperpigmentation; Melanosis

Most Recent Events

  • 04 Jan 2018 inVentiv Health has merged with INC Research to form Syneos Health
  • 22 Jul 2009 Stiefel Laboratories has been acquired by GlaxoSmithKline
  • 06 Aug 2008 Barrier Therapeutics Inc has been acquired by Stiefel Laboratories
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top